patent/US-2007213264-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007213264-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58d1b8bb61fb98c7dc9413a2cd6bb0e1
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4756
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-30
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
filingDate	2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_244cfae34c3800c66c29dc5c8897b380
publicationDate	2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	US-2007213264-A1
titleOfInvention	Neuregulin variants and methods of screening and using thereof
abstract	The present invention provides polypeptide variants of neuregulin-1β (NRG-1β) that have enhanced or decreased binding affinity to ErbB3 and/or ErbB4. The invention also provides methods of screening and producing polypeptide variants of NRG-1β and methods of using polypeptide variants of NRG-1β for treating diseases.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011229444-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956266-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010256066-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10813978-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198951-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350269-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8476405-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022261299-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012121557-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964555-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9340597-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253573-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3338791-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011166068-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2320933-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2320933-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012400-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785387-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561709-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894815-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638746-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015239948-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9655949-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009156488-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007190127-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10112983-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007129296-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555076-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9434777-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11246909-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441633-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011230412-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007264254-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3632459-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179323-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11235031-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609620-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089524-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011135595-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194734-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010144781-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10098834-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7612164-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010096117-A2
priorityDate	2005-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359272

Total number of triples: 89.